ArticleCroatian medical journal2016

Imatinib and dasatinib as salvage therapy for sclerotic chronic graft-vs-host disease.

Isabel Sánchez-Ortega et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.